Given that mTORC1‐hyperactivity is a hallmark driver of TSC‐associated tumours, TSC preclinical models are commonly used to study mTORC1‐active tumour biology (Dodd & Dunlop, 2016). The gene discussed is TSC1; the disease is neoplasm.